228 related articles for article (PubMed ID: 32099332)
21. Bis-isatin hydrazones with novel linkers: Synthesis and biological evaluation as cytotoxic agents.
Ibrahim HS; Abou-Seri SM; Ismail NSM; Elaasser MM; Aly MH; Abdel-Aziz HA
Eur J Med Chem; 2016 Jan; 108():415-422. PubMed ID: 26706352
[TBL] [Abstract][Full Text] [Related]
22. The Anti-Breast Cancer Potential of Bis-Isatin Scaffolds.
Guo H; Diao QP
Curr Top Med Chem; 2020; 20(16):1499-1503. PubMed ID: 32156238
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of new indole containing biaryl derivatives as potent antiproliferative agents.
Yuan S; Feng SQ; Li AQ; Zuo JH; Zhang DQ; Xing YJ; Xie Z; Yu B; Liu HM
Bioorg Chem; 2021 May; 110():104821. PubMed ID: 33812156
[TBL] [Abstract][Full Text] [Related]
24. Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling.
Abdel-Aziz HA; Eldehna WM; Keeton AB; Piazza GA; Kadi AA; Attwa MW; Abdelhameed AS; Attia MI
Drug Des Devel Ther; 2017; 11():2333-2346. PubMed ID: 28848327
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer.
Duan YC; Jin LF; Ren HM; Zhang SJ; Liu YJ; Xu YT; He ZH; Song Y; Yuan H; Chen SH; Guan YY
Eur J Med Chem; 2021 Aug; 220():113453. PubMed ID: 33957387
[TBL] [Abstract][Full Text] [Related]
26. Design, combinatorial synthesis and biological evaluations of novel 3-amino-1'-((1-aryl-1H-1,2,3-triazol-5-yl)methyl)-2'-oxospiro[benzo[a] pyrano[2,3-c]phenazine-1,3'-indoline]-2-carbonitrile antitumor hybrid molecules.
Lu Y; Wang L; Wang X; Xi T; Liao J; Wang Z; Jiang F
Eur J Med Chem; 2017 Jul; 135():125-141. PubMed ID: 28441581
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, anticancer and apoptosis-inducing activities of quinazoline-isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies.
El-Azab AS; Al-Dhfyan A; Abdel-Aziz AA; Abou-Zeid LA; Alkahtani HM; Al-Obaid AM; Al-Gendy MA
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):935-944. PubMed ID: 28718672
[TBL] [Abstract][Full Text] [Related]
28. Isatin derivatives with activity against apoptosis-resistant cancer cells.
Evdokimov NM; Magedov IV; McBrayer D; Kornienko A
Bioorg Med Chem Lett; 2016 Mar; 26(6):1558-1560. PubMed ID: 26883150
[TBL] [Abstract][Full Text] [Related]
29. Artemisinin-isatin hybrids tethered via ethylene linker and their anti-lung cancer activity.
Wang R; Zhang Q; Chen M
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200563. PubMed ID: 36572639
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of novel 1H-1,2,3-triazole tethered C-5 substituted uracil-isatin conjugates and their cytotoxic evaluation.
Kumar K; Sagar S; Esau L; Kaur M; Kumar V
Eur J Med Chem; 2012 Dec; 58():153-9. PubMed ID: 23124212
[TBL] [Abstract][Full Text] [Related]
31.
Adibi H; Beyhaghi E; Hayati S; Hosseinzadeh L; Amin N
Anticancer Agents Med Chem; 2022; 22(13):2439-2447. PubMed ID: 35043767
[TBL] [Abstract][Full Text] [Related]
32. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
33. Discovery of indolin-2-one derivatives as potent PAK4 inhibitors: Structure-activity relationship analysis, biological evaluation and molecular docking study.
Guo J; Zhu M; Wu T; Hao C; Wang K; Yan Z; Huang W; Wang J; Zhao D; Cheng M
Bioorg Med Chem; 2017 Jul; 25(13):3500-3511. PubMed ID: 28502459
[TBL] [Abstract][Full Text] [Related]
34. Fe3O4 Nanoparticles Mediated Synthesis of Novel Isatin-dihydropyrimidinone Hybrid Molecules as Antioxidant and Cytotoxic Agents.
Maddela S; Makula A; Jayarambabu N
Anticancer Agents Med Chem; 2017; 17(3):456-463. PubMed ID: 27173964
[TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of thiadiazolo-carboxamide bridged β-carboline-indole hybrids: DNA intercalative topo-IIα inhibition with promising antiproliferative activity.
Tokala R; Sana S; Lakshmi UJ; Sankarana P; Sigalapalli DK; Gadewal N; Kode J; Shankaraiah N
Bioorg Chem; 2020 Dec; 105():104357. PubMed ID: 33091673
[TBL] [Abstract][Full Text] [Related]
36. Development of 2-oindolin-3-ylidene-indole-3-carbohydrazide derivatives as novel apoptotic and anti-proliferative agents towards colorectal cancer cells.
Eldehna WM; Abo-Ashour MF; Al-Warhi T; Al-Rashood ST; Alharbi A; Ayyad RR; Al-Khayal K; Abdulla M; Abdel-Aziz HA; Ahmad R; El-Haggar R
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):319-328. PubMed ID: 33345633
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and QSAR study of novel isatin analogues inspired Michael acceptor as potential anticancer compounds.
Wang J; Yun D; Yao J; Fu W; Huang F; Chen L; Wei T; Yu C; Xu H; Zhou X; Huang Y; Wu J; Qiu P; Li W
Eur J Med Chem; 2018 Jan; 144():493-503. PubMed ID: 29288946
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and antiproliferative activity of a novel class of indole-2-carboxylate derivatives.
Ji XY; Xue ST; Zhan YC; Shen JJ; Wu LT; Jin J; Wang Z; Li ZR
Eur J Med Chem; 2014 Aug; 83():409-18. PubMed ID: 24996136
[TBL] [Abstract][Full Text] [Related]
40. Antiproliferative effects of metal complexes of new isatin hydrazones against HCT116, MCF7 and HELA tumour cell lines.
Kandile NG; Mohamed MI; Ismaeel HM
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):330-8. PubMed ID: 21699460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]